Artículos por temáticas

Improved cognitive and memory abilities in a patient with Alzheimer's disease treated with activated immune cells: Immune cell therapy may benefit more AD patients

Laumbacher B, Fellerhoff-Loesch B, Wank R.

Med Hypotheses. 2017 Feb;99:19-22. doi: 10.1016/j.mehy.2016.12.001. Epub 2016 Dec 5.

The pertussis hypothesis: Bordetella pertussis colonization in the pathogenesis of Alzheimer's disease

Rubin K, Glazer S.

Immunobiology. 2017 Feb;222(2):228-240. doi: 10.1016/j.imbio.2016.09.017. Epub 2016 Sep 28.

Mortality in dementia with Lewy bodies compared with Alzheimer's dementia: a retrospective naturalistic cohort study

Price A, Farooq R, Yuan JM, Menon VB, Cardinal RN, O'Brien JT.

BMJ Open. 2017 Nov 3;7(11):e017504. doi: 10.1136/bmjopen-2017-017504.

Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer's disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database

Ben Bouallègue F, Mariano-Goulart D, Payoux P; Alzheimer’s Disease Neuroimaging Initiative (ADNI).

Alzheimers Res Ther. 2017 Apr 26;9(1):32. doi: 10.1186/s13195-017-0260-z.

Bilingualism as a strategy to delay the onset of Alzheimer's disease

Klimova B, Valis M, Kuca K.

Clin Interv Aging. 2017 Oct 19;12:1731-1737. doi: 10.2147/CIA.S145397. eCollection 2017.

Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer Disease: A Meta-analysis

Neu SC, Pa J, Kukull W, Beekly D, Kuzma A, Gangadharan P, Wang LS, Romero K, Arneric SP, Redolfi A, Orlandi D, Frisoni GB, Au R, Devine S, Auerbach S, Espinosa A, Boada M, Ruiz A, Johnson SC, Koscik R

JAMA Neurol. 2017 Oct 1;74(10):1178-1189. doi: 10.1001/jamaneurol.2017.2188.

Motor Abnormalities: From Neurodevelopmental to Neurodegenerative Through "Functional" (Neuro)Psychiatric Disorders

Peralta V, Cuesta MJ.

Schizophr Bull. 2017 Sep 1;43(5):956-971. doi: 10.1093/schbul/sbx089.

African American Dementia Caregiver Problem Inventory: Descriptive analysis and initial psychometric evaluation

Wells BA, Glueckauf RL, Bernabe D, Kazmer MM, Schettini G, Springer J, Sharma D, Meng H, Willis FB, Graff-Radford N.

Rehabil Psychol. 2017 Feb;62(1):25-35. doi: 10.1037/rep0000110. Epub 2016 Dec 15.

What Drives Country Differences in Cost of Alzheimer's Disease? An Explanation from Resource Use in the GERAS Study

Reed C, Happich M, Argimon JM, Haro JM, Wimo A, Bruno G, Dodel R, Jones RW, Vellas B, Belger M.

J Alzheimers Dis. 2017;57(3):797-812. doi: 10.3233/JAD-160449.

Evidence for benefit of statins to modify cognitive decline and risk in Alzheimer's disease

Geifman N, Brinton RD, Kennedy RE, Schneider LS, Butte AJ.

Alzheimers Res Ther. 2017 Feb 17;9(1):10. doi: 10.1186/s13195-017-0237-y.

Low LDL cholesterol, PCSK9 and HMGCR genetic variation, and risk of Alzheimer's disease and Parkinson's disease: Mendelian randomisation study

Benn M, Nordestgaard BG, Frikke-Schmidt R, Tybjærg-Hansen A.

BMJ. 2017 Apr 24;357:j1648. doi: 10.1136/bmj.j1648.

ATP binding cassette subfamily A member 7 rs3764650 polymorphism and the risk of Alzheimer's disease

Zhou G, Mao X, Chu J, Chen G, Zhao Q, Wang L, Luo Y.

Pharmazie. 2017 Jul 3;72(7):425-427. doi: 10.1691/ph.2017.6862.

Caregiver Preference and Treatment Compliance in Patients with Mild-to-Moderate Alzheimer's Disease in South Korea: RECAP Study Results

Lee KJ, Cho SJ, Kim BC, Park M, Lee JH.

Adv Ther. 2017 Feb;34(2):481-494. doi: 10.1007/s12325-016-0465-8. Epub 2016 Dec 20.

APOE ε4 allele elevates the expressions of inflammatory factors and promotes Alzheimer's disease progression: A comparative study based on Han and She populations in the Wenzhou area

Fan YY, Cai QL, Gao ZY, Lin X, Huang Q, Tang W, Liu JH.

Brain Res Bull. 2017 Jun;132:39-43. doi: 10.1016/j.brainresbull.2017.04.017. Epub 2017 Apr 29.

Strengthening the Case for Epilepsy Drug Development: Bridging Experiences from the Alzheimer's Disease Field-An Opinion

Twyman RE.

Neurochem Res. 2017 Jul;42(7):2099-2115. doi: 10.1007/s11064-017-2300-2. Epub 2017 Jun 7.